Previous Close | 1.2550 |
Open | 1.2700 |
Bid | 0.0000 x 1300 |
Ask | 0.0000 x 800 |
Day's Range | 1.2700 - 1.4300 |
52 Week Range | 0.7500 - 7.4400 |
Volume | |
Avg. Volume | 7,629 |
Market Cap | 8.2M |
Beta (5Y Monthly) | -1.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -9.6400 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.00 |
Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced first quarter 2024 financial results and related highlights.
Onymos, developer of the world's first Features-as-a-Service platform, and Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm"), a global medical technology company whose proprietary high-velocity therapy® products treat patients of all ages suffering from respiratory distress, today announced the formation of a development and commercialization partnership. This partnership will help Vapotherm create a unique respiratory digital platform to meet its data visualization and device management goals for th
Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.